OienRFHakanssonAOvhedIHansenBU. Wound management for 287 patients with chronic leg ulcers demands 12 full-time nurses. Leg ulcer epidemiology and care in a well-defined population in southern Sweden. Scand J Prim Health Care2000;18:220–5.
2.
GrahamIDHarrisonMBNelsonEA. Prevalence of lower-limb ulceration: A systematic review of prevalence studies. Adv Skin Wound Care2003;16:305–16.
3.
ForssgrenAFranssonINelzenO. Leg ulcer point prevalence can be decreased by broad-scale intervention: A follow-up cross-sectional study of a defined geographical population. Acta Derm Venereol2008;88:252–6.
4.
MarstonWADaviesSWArmstrongB. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg2006;44:108–14.
5.
NorgrenLHiattWRDormandyJA. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg2007;45Suppl S:S5–67.
6.
Second European Consensus Document on chronic critical leg ischemia. Eur J Vasc Surg1992;6Suppl A:1–32.
7.
HirschATHaskalZJHertzerNR. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary. A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol2006;47:1239–312.
8.
Lloyd-JonesDAdamsRCarnethonM. Heart disease and stroke statistics—2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published erratum appears in Circulation 2009;119: E182]. Circulation.2009;119:e21–181. Epub 2008 Dec 15.
McGeeSRBoykoEJ. Physical examination and chronic lower-extremity ischemia: A critical review. Arch Intern Med1998;158:1357–64.
11.
HiattWR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med2001;344:1608–21.
12.
HafnerJSchaadISchneiderE. Leg ulcers in peripheral arterial disease (arterial leg ulcers): Impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol2000;43:1001–8.
13.
WolfeJHWyattMG. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg1997;13:578–82.
14.
Gerhard-HermanMGardinJMJaffM. Guidelines for noninvasive vascular laboratory testing: A report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med2006;11:183–200.
15.
FagliaEClericiGCaminitiM. Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia. Eur J Vasc Endovasc Surg2007;33:731–6.
16.
YamadaTOhtaTIshibashiH. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs—comparison with other noninvasive diagnostic methods. J Vasc Surg.2008;47:318–23.
17.
WutschertRBounameauxH. Predicting healing of arterial leg ulcers by means of segmental systolic pressure measurements. Vasa Suppl1998;27:224–8.
18.
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ2002;324(7329):71–86.
19.
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet1996; 348(9038):1329–39.
20.
BhattDLFoxKAHackeW. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med2006;354:1706–17.
21.
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg2007;45:645–54.
22.
OstergrenJSleightPDagenaisG. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J2004;25:17–24.
23.
SlovutDPSullivanTM. Critical limb ischemia: Medical and surgical management. Vasc Med2008;13:281–91.
24.
SantilliJDSantilliSM. Chronic critical limb ischemia: Diagnosis, treatment and prognosis. Am Fam Physician1999;59:1899–908.
25.
De VriesJDe JongsteMJSpincemailleGStaalMJ. Spinal cord stimulation for ischemic heart disease and peripheral vascular disease. Adv Tech Stand Neurosurg2007;32:63–89.
26.
KalkaCBaumgartnerI. Gene and stem cell therapy in peripheral arterial occlusive disease. Vasc Med2008;13:157–72.
27.
KavrosSJDelisKTTurnerNS. Improving limb salvage in critical ischemia with intermittent pneumatic compression: A controlled study with 18-month follow-up. J Vasc Surg2008;47:543–9.
GrahamIDHarrisonMBLorimerK. Adapting national and international leg ulcer practice guidelines for local use: The Ontario Leg Ulcer Community Care Protocol. Adv Skin Wound Care2005;18:307–18.
30.
HirschATCriquiMHTreat-JacobsonD. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA2001;286:1317–24.
